Andrew D. Goldberg insider trades

Open-market stock purchases and sales by Andrew D. Goldberg, Director at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 15, 2021.

Recent trades

DateStockTradeValue
Jun 25, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Jun 25, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Jun 12, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Apr 18, 2026ACHV Achieve Life Sciences, IncBought (not open market)—
Apr 18, 2026ACHV Achieve Life Sciences, IncBought (not open market)—
Apr 18, 2026ACHV Achieve Life Sciences, IncBought (not open market)—

Companies traded

  • TARS Tarsus Pharmaceuticals, Inc: 1 buy, last Jun 25, 2026
  • ACHV Achieve Life Sciences, Inc: other filings, last Apr 18, 2026

Get free alerts when Andrew D. Goldberg files a new trade →